Royalty Report: Medical, Diagnostic, Device – Collection: 29218

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Medical
  • Diagnostic
  • Device

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 29218

License Grant
The Licensors (the University and the Institute) both grant to Licensee an exclusive license, including the right to grant sublicenses, under Licensors' interests in the Licensed Patents, the Collaboration Licensed Patents and the Licensed Data, to make, have made, use, offer to sell, sell, have sold, distribute, have distributed, import and export Licensed Products in the Licensed Territory in the Licensed Field.  The Company obtained an exclusive, royalty-bearing license, including right to grant sublicenses, for the University’s collaborative licensed technology pertaining to neural signal decoding.
License Property
The licensed technology relates to animal implants and related systems, devices and components for the purposes of researching, developing and testing Licensed Products for human use.

Licensed Product shall mean any product the manufacture, use or sale of which would, absent the licenses granted by the Licensors to Licensees herein, infringe any Valid Claim included in any Licensed Patent.

The technology is intended to allow for intra-operative and post-operative monitoring of numerous neurological diseases and disorders.

Field of Use
The Licensed Field shall mean all fields, except as follows  
a) as to any Limited Field Patent of first Licensor,the licensed field shall mean use in humans or animals as, in connection with or as part of any biomedical system or device, including, without limitation, any medical or biomedical application (e.g., for the treatment, diagnosis or prevention of any disease or medical condition or for use as or in connection with brain or other implants in healthy individuals), and
b) as to any Collaboration Licensed Patent of the second Licensor, the licensed field shall mean use as,  in connection with or as part of any system or device or component thereof for the detection, recording, transmission (via cables, wirelessly or otherwise), generation, stimulation and/or decoding of electrical or other activity in the human brain or human central or peripheral nervous system for any medical, biological or biomedical or other purpose.

IPSCIO Record ID: 29217

License Grant
The University grants Licensee and its Affiliates an exclusive, sublicenseable license under Licensor's interests and rights in the Licensed Technology to make, have made, use, import, offer for sale, and sell Licensed Products in the Licensed Territory and in the Licensed Field during the term of this Agreement.  The Company obtained an exclusive license from the University for a patent covering a system that achieves a brain-machine interface by processing multicellular brain signals.
License Property
The patent is for Systems, methods and devices for controlling external devices by signals derived directly from the nervous system.
Field of Use
Field of Use relates to research and development in medical devices for the healthcare industry.

IPSCIO Record ID: 289542

License Grant
If, and only if, Licensor exercises its option for a license under the CIC Patents pursuant to this agreement, Licensor shall grant (and will cause its Affiliates to grant) to Licensee and its Affiliates the right and option until the expiration of thirty (30) months from the Effective Date or ninety (90) days from the date Licensor exercises its option, whichever is later in time, to obtain a non-exclusive, worldwide, non-transferable, royalty-bearing license under the Savacor Patents.
License Property
Savacor Patents shall mean those patents and patent applications, and all patents and patent applications claiming priority therefrom, that Licensor or its Affiliates acquired from Savacor, Ind. as set forth.  The Savacor Patents shall include the sublicensable patents and patent applications of Cedars Sinai Medical Center listed.

6,970,742 – Method for detecting, diagnosing, and treating cardiovascular disease
6,328,699 – Permanently implantable system and method for detecting, diagnosing and treating congestive heart failure

Field of Use
“CRM Products” means devices for monitoring or electrically stimulating or shocking the heart which are suitable for chronic implantation, in whole or in part, by or with human patients. The term “CRM Products” includes, without limitation cardiac pacemakers, antitachycardia pacemakers, cardiac resynchronization therapy systems, cardioverters, and defibrillators, including combinations thereof; loop recording systems, implantable cardiac monitoring systems, implantable hemodynamic monitoring systems, pulse generators and other waveform generators for such devices; cardiac lead implant catheters and associated tools; leads, electrodes, sensors, capacitors, batteries, power sources, and all other components for such devices; mechanisms for coupling such generators in a stimulating, shocking, sensing, or monitoring relationship to the heart; and data dispensing, processing, and gathering systems for such devices, including programmers, pacing system analyzers, defibrillation system analyzers, testers, encoders, decoders, transtelephonic and other remote monitoring systems and services for use with implantable devices, transmitters, receivers, and computer software-controlled systems, and including the software. The term “CRM Products” excludes, by way of example and not limitation, nerve stimulators (unless used for cardiac therapy), bone growth stimulators, drug release pumps, cardiac pumps, artificial hearts, prosthetic heart valves, catheter ablation devices, imaging systems, catheter location systems, apparatus for revascularization or correction of other physical defects in heart tissue, arrhythmia mapping devices (except as part of an implantable cardiac therapy or monitoring device), angioplasty devices and EKG monitors (other than cardiac stimulation device programmers or other telemetry devices for use with implantable pulse generators or cardiac monitors) which are standalone, non-ambulatory and not intended for transtelephonic or other remote monitoring.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.